These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 14502358

  • 1. Effect of hydroxyurea on G gamma chain fetal hemoglobin synthesis by sickle-cell disease patients.
    Teixeira SM, Cortellazzi LC, Grotto HZ.
    Braz J Med Biol Res; 2003 Oct; 36(10):1289-92. PubMed ID: 14502358
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease.
    Gordeuk VR, Campbell A, Rana S, Nouraie M, Niu X, Minniti CP, Sable C, Darbari D, Dham N, Onyekwere O, Ammosova T, Nekhai S, Kato GJ, Gladwin MT, Castro OL.
    Blood; 2009 Nov 19; 114(21):4639-44. PubMed ID: 19724057
    [Abstract] [Full Text] [Related]

  • 5. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
    Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG.
    J Clin Invest; 1984 Aug 19; 74(2):652-6. PubMed ID: 6205021
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA.
    Adv Pediatr; 1996 Aug 19; 43():309-34. PubMed ID: 8794181
    [No Abstract] [Full Text] [Related]

  • 9. Effects of hydroxyurea in a population of Brazilian patients with sickle cell anemia.
    Vicari P, Barretto de Mello A, Figueiredo MS.
    Am J Hematol; 2005 Mar 19; 78(3):243-4. PubMed ID: 15726590
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
    Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M.
    JAMA; 2003 Apr 02; 289(13):1645-51. PubMed ID: 12672732
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hydroxyurea for sickle cell anemia.
    Naina HV, Harris S.
    N Engl J Med; 2008 Jul 03; 359(1):98; author reply 98-9. PubMed ID: 18596283
    [No Abstract] [Full Text] [Related]

  • 14. Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease.
    Hoppe C, Vichinsky E, Quirolo K, van Warmerdam J, Allen K, Styles L.
    J Pediatr Hematol Oncol; 2000 Jul 03; 22(4):330-4. PubMed ID: 10959903
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].
    Nkashama GM, Wakamb GK, Mulangu AM, Nkashama GM, Kupa BK, Numbi OL.
    Pan Afr Med J; 2015 Jul 03; 21():124. PubMed ID: 26327961
    [Abstract] [Full Text] [Related]

  • 17. Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia.
    Fitzhugh CD, Hsieh MM, Allen D, Coles WA, Seamon C, Ring M, Zhao X, Minniti CP, Rodgers GP, Schechter AN, Tisdale JF, Taylor JG.
    PLoS One; 2015 Jul 03; 10(11):e0141706. PubMed ID: 26576059
    [Abstract] [Full Text] [Related]

  • 18. Hydroxyurea, sickle cell disease and renal transplantation.
    Allen A, Scoble J, Snowden S, Hambley H, Bellingham A.
    Nephron; 1997 Jul 03; 75(1):106-7. PubMed ID: 9031282
    [No Abstract] [Full Text] [Related]

  • 19. α:Non-α and Gγ:Aγ globin chain ratios in thalassemia intermedia patients treated with hydroxyurea.
    Najjari A, Asouri M, Gouhari LH, Niaki HA, Nejad AS, Eslami SM, Abolghasemi H, Ataee R, Ebrahimi AA, Moshaei MR, Ahmadi AA.
    Asian Pac J Trop Biomed; 2014 May 03; 4(Suppl 1):S177-85. PubMed ID: 25183077
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.